Magnetic stimulation for movement symptoms in Huntington's disease
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests whether a non-invasive magnetic device (placed on the head) can help reduce involuntary movements (chorea) in people with Huntington's disease. It aims to see if this gentle stimulation can improve movement control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic test confirming Huntington's disease (CAG repeat count of 36 or more).
- You have noticeable involuntary movements (chorea) as rated by a doctor on a standard scale.
- You have been on the same medications for at least 8 weeks, and agree not to change them during the study.
- You are not pregnant or breastfeeding, and have no metal implants or devices that would make magnetic stimulation unsafe.
- You are willing to give written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a gentle brain stimulation device (tDCS) used at home can help improve thinking and behavior in people with Huntington's disease. A caregiver is needed to be present during treatment and help with questionnaires.
This trial tests an at-home, noninvasive brain stimulation treatment to help with behavioral and cognitive (thinking) symptoms in people with Huntington’s disease. You and a caregiver work together during sessions and questionnaires to see if symptoms improve and stay stable.
This trial tests a new focused ultrasound technique aimed at reducing involuntary movements (chorea) in people with Huntington's disease. The treatment targets a specific brain region and may help improve movement control and quality of life.
This study uses a small wearable sensor to measure walking and movement in people with Huntington's disease and healthy volunteers. It aims to find better ways to monitor the disease, which could help improve future care.
This study uses smartphone and wearable sensors to track movement and thinking in people with Huntington's disease. It aims to find better ways to measure how the disease progresses in clinical trials.
This study uses special brain imaging and memory/thinking tests to find early “markers” that can predict how Huntington’s disease will progress over time. You may qualify as someone with early-stage Huntington’s or as a healthy control, if you meet specific safety and scoring requirements.
Hear when a new Huntington Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.